Skip to the page

Data / Public companies / SIC 8011: Offices and clinics of doctors of medicine / Concord Medical Services Holdings LTD

Concord Medical Services Holdings LTD: revenue, net income and total assets from its latest annual report

Updated April 29, 2026. Source: SEC Financial Statement Data Sets, filing 0001104659-26-050692.

Concord Medical Services Holdings LTD reported revenue of $65.9 million, a net loss of $13.3 million and total assets of $936.3 million for the fiscal year ended December 31, 2025, in its annual report (20-F) filed with the SEC on April 29, 2026. It ranks 65th by revenue of 88 companies in SIC 80xx, industries with the same first two SIC digits.

The request: Watch Concord Medical Services Holdings LTD (CIK 1472072): each new SEC filing, with revenue and net income. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.

SEC central index key (CIK)
1472072
Industry
SIC 8011, Offices and clinics of doctors of medicine
Business address (city and state)
Chaoyang District, Beijing
Incorporated in
Kentucky
Filer category
Non-accelerated filer
Fiscal year ends
December 31
Latest annual report
20-F filed April 29, 2026
Annual and quarterly reports in the data
1 annual, 0 quarterly

Financials for the fiscal year ended December 31, 2025

As filed, in US dollars. The prior year value is the comparison column in the same report.

ItemThis yearPrior yearChangeSource
Revenue$65,852,000Not listedNot listedsec.gov
Operating income$-37,393,000Not listedNot listedsec.gov
Net income$-13,271,000Not listedNot listedsec.gov
Total assets$936,260,000Not listedNot listedsec.gov
Total liabilities$671,697,000Not listedNot listedsec.gov
Stockholders' equity$-300,741,000Not listedNot listedsec.gov
Cash and cash equivalents$42,583,000Not listedNot listedsec.gov

How it compares

Net margin (net income over revenue)
-20.2%
Revenue rank in SIC 80xx
65th of 88
Revenue rank among all companies in the data
2,973rd of 4,486

Companies next to it by revenue in SIC 80xx

Industries with the same first two SIC digits, from the same data.

CompanyBusiness addressRevenueNet incomeTotal assetsRevenue change
Biodesix IncLouisville, CO$88.5 million$-35,265,000$87.5 million24.1%
Burning Rock Biotech LTDGuangzhou, Guangdong$77.2 million$-7,916,000$117.3 millionNot listed
Personalis, Inc.Fremont, CA$69.6 million$-81,270,000$334.2 million-17.7%
Exagen Inc.Vista, CA$66.6 million$-19,951,000$58 million19.7%
Cryo Cell International IncOldsmar, FL$31.6 million$-2,429,385$61.7 million-1.3%
Capforce Inc.Rockville, MD$30.2 million$23.6 million$38.1 million481.2%
American Shared Hospital ServicesSan Francisco, CA$28.1 million$-1,553,000$55.5 million-0.9%
Ethema Health CorpWest Palm Beach, FL$18.8 million$-2,177,669$28.8 million211.9%

Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.